Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Division of Gastroenterology (Liver Unit), University of Alberta Hospital, Edmonton, AB, Canada.
Hepatology. 2019 Dec;70(6):2193-2203. doi: 10.1002/hep.30686.
Sarcopenia is a common complication of cirrhosis and is defined as a progressive and generalized loss of skeletal muscle mass, strength, and function. Sarcopenia is associated with poor prognosis and increased mortality. How sarcopenia and muscle wasting relate to such poor outcomes requires looking beyond the overt muscle loss and at this entity as a systemic disease that affects muscles of vital organs including cardiac and respiratory muscles. This review explores the pathophysiological pathways and mechanisms that culminate in poor outcomes associated with sarcopenia. This provides a launching pad to identify potential targets for therapeutic intervention and optimization to improve patient outcomes.
肌肉减少症是肝硬化的常见并发症,定义为骨骼肌质量、力量和功能的进行性和全身性丧失。肌肉减少症与预后不良和死亡率增加有关。肌肉减少症和肌肉消耗与如此不良结局的关系需要超越明显的肌肉损失,并将其视为一种影响包括心脏和呼吸肌在内的重要器官肌肉的系统性疾病。本综述探讨了导致与肌肉减少症相关的不良结局的病理生理途径和机制。这为确定潜在的治疗干预和优化目标以改善患者结局提供了一个起点。